NCT04297384 - Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Breast CarcinomaMetastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8Recurrent Breast Carcinoma

Interventions

OTHER

Informational Intervention

Receive standard chemotherapy educational materials

OTHER

Informational Intervention

Receive personalized information about cancer, treatment, and side effects

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Complete surveys

Trial Locations (1)

Roswell Park Cancer Institute, Buffalo